Effective with date of service Dec. 22, 2021, Medicaid and NC Health Choice cover inclisiran injection, for subcutaneous use (Leqvio®).
Blog Entry List
Effective with date of service Dec. 17, 2021, Medicaid and NC Health Choice cover efgartigimod alfa-fcab injection, for intravenous use (VYVGART™).
Effective with date of service Dec. 30, 2021, Medicaid and NC Health Choice cover ropeginterferon alfa-2b-njft injection, for subcutaneous use (BESREMI®).
Follow-Up information after Office Hours and provider questions
Submission deadline extended from Feb. 4 to Feb. 11, 2022
Charter schools, as Local Education Agencies, are to participate in North Carolina Medicaid reimbursement.
New DCW Initiative resource for providers
Certain COVID-19 Flexibilities implemented by NC Medicaid under State Authority will end as of March 31, 2022
Desk reviews of round two AMH+ practices/ CMAs provider applications are completed and 32 providers advanced to the site review stage.
Provider manual updated, guidance on the use of extenders, updated rate guidance and webinar series FAQs.
Changes to details regarding eligibility, timelines and provider requirements
Update to Special Bulletin COVID-19 #213: Direct Care Worker ICF-IID Wage Increase. Please review the updated bulletin in its entirety for details.
Upcoming Key Milestones, Playbook Updates, COVID-19 Vaccine Incentive Program, Provider Authorizations, Provider Ombudsman and more.
Additional flexibilities to support hospitals
The following guidance applies to AMH Tier 3 practices not participating in the NC Integrated Care for Kids (InCK) pilot project.